Tag: GDP

GDP Deviations: Identification, Investigation and Documentation Step-by-Step Guide to Managing GDP Deviations in Pharma Supply Chain and Cold Chain Processes Good Distribution Practice (GDP) is a critical component in maintaining the quality and integrity of medicinal products throughout the supply chain. In pharmaceutical distribution, warehousing, and cold chain logistics, deviations from established GDP standards can…

Read More “GDP Deviations: Identification, Investigation and Documentation” »

Creating an Investigation Framework for Supply Chain Temperature Failures Step-by-Step Tutorial: Creating an Investigation Framework for Supply Chain Temperature Failures Maintaining the integrity of pharmaceutical products during supply chain operations is a critical responsibility for companies operating within the US, UK, and EU markets. Temperature management, especially in cold chain logistics, plays a pivotal role…

Read More “Creating an Investigation Framework for Supply Chain Temperature Failures” »

Chain of Custody Requirements for High-Risk and Temperature-Sensitive Products Implementing Chain of Custody Requirements for High-Risk and Temperature-Sensitive Pharma Products Maintaining a secure, compliant, and robust chain of custody is essential when managing high-risk and temperature-sensitive pharmaceutical products throughout the pharma supply chain. Ensuring product integrity demands strict adherence to Good Distribution Practice (GDP) regulations…

Read More “Chain of Custody Requirements for High-Risk and Temperature-Sensitive Products” »

GDP for Clinical Trial Supplies: Packaging, Labelling and Shipment Controls Good Distribution Practice (GDP) for Clinical Trial Supplies: Packaging, Labelling, and Shipment Controls Effective control of clinical trial supplies is critical to ensuring the integrity, safety, and efficacy of investigational medicinal products (IMPs) throughout the pharmaceutical supply chain. Good Distribution Practice (GDP) requirements harmonize regulations…

Read More “GDP for Clinical Trial Supplies: Packaging, Labelling and Shipment Controls” »

Import–Export GDP: Customs, Delays and Temperature Risk Controls Comprehensive Guide to Import–Export GDP: Managing Customs, Delays, and Temperature Risk Controls in the Pharma Supply Chain In global pharmaceutical distribution, ensuring compliance with Good Distribution Practice (GDP) during import-export operations is critical to maintain product integrity, particularly within the cold chain. This tutorial outlines a step-by-step…

Read More “Import–Export GDP: Customs, Delays and Temperature Risk Controls” »

Handling Product Returns: Visual Inspection, Storage and Decision-Making in Pharma Supply Chain Handling Product Returns: A Step-by-Step Guide for Visual Inspection, Storage, and Decision-Making in GDP Efficient and compliant management of product returns within the pharmaceutical supply chain is a critical component of Good Distribution Practice (GDP), especially when adhering to regulatory frameworks across the…

Read More “Handling Product Returns: Visual Inspection, Storage and Decision-Making” »

Reconciliation and Documentation for Returned Goods Comprehensive Step-by-Step Guide to Reconciliation and Documentation for Returned Goods in Pharma Supply Chain The management of returned goods within pharmaceutical supply chains necessitates rigorous adherence to Good Distribution Practice (GDP), comprehensive reconciliation procedures, and proper documentation to ensure product quality, patient safety, and regulatory compliance. This tutorial provides…

Read More “Reconciliation and Documentation for Returned Goods” »

Raw Material Supply Chain Risks: Vendor Qualification and Testing Comprehensive Step-by-Step Guide on Raw Material Supply Chain Risks, Vendor Qualification, and Testing Managing the pharmaceutical supply chain presents unique and critical challenges, especially concerning raw material sourcing, vendor qualification, and testing processes. Effective implementation of Good Distribution Practice (GDP), cold chain management, and warehousing controls…

Read More “Raw Material Supply Chain Risks: Vendor Qualification and Testing” »

Vendor Qualification Under GDP: Audit, Approval and Monitoring Vendor Qualification Under GDP: A Step-by-Step Guide to Audit, Approval, and Monitoring Ensuring compliance with Good Distribution Practice (GDP) during vendor qualification is critical for maintaining the integrity, safety, and quality of pharmaceutical products throughout the supply chain. Pharmaceutical companies operating in the US, UK, and EU…

Read More “Vendor Qualification Under GDP: Audit, Approval and Monitoring” »

Supplier Quality Agreements: Must-Have Clauses and Enforcement Essential Guide to Supplier Quality Agreements for GDP and Cold Chain Compliance Supplier Quality Agreements (SQAs) are pivotal documents within the pharmaceutical supply chain, especially given the complex regulatory environment surrounding GDP (Good Distribution Practice), cold chain management, and warehousing. For pharmaceutical manufacturers and distributors operating across the…

Read More “Supplier Quality Agreements: Must-Have Clauses and Enforcement” »